Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)

OBJECTIVE: It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on cardiovascular outcomes varied by different LDL-cholesterol levels at baseline in EMPA-REG OUTCOME. METHOD...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diab Vasc Dis Res
Egile Nagusiak: Langslet, Gisle, Zinman, Bernard, Wanner, Christoph, Hantel, Stefan, Espadero, Rosa-Maria, Fitchett, David, Johansen, Odd Erik
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2020
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919220/
https://ncbi.nlm.nih.gov/pubmed/33307785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164120975256
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak